Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments

Neurology

Volumn 77, Issue 21, 2011, Pages 1906-1912

  Peltz, Carrie B ^a,b   Corrada, María M ^a,b   Berlau, Daniel J ^a   Kawas, Claudia H ^a,b,c  

^a Institute for Memory Impairments and Neurological Disorders   (United States)

^b Department of Neurology ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; ALLELE; AMNESTIC MILD COGNITIVE IMPAIRMENT; ARTICLE; COGNITIVE DEFECT; DEMENTIA; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NONAMNESTIC MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 82955225343     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318238ee89     Document Type: Article

References (34)

1. Gao S, Hendrie HC, Hall KS, Hui S. The relationships between age, sex, and the incidence of dementia and Alz-heimer disease: A meta-analysis. Arch Gen Psychiatry 1998;55:809-815. (Pubitemid 28413043)
2. Jorm AF, Jolley D. The incidence of dementia: A metaanalysis. Neurology 1998;51:728-733.
3. Corrada MM, Brookmeyer R, Paganini-Hill A, Berlau D, Kawas CH. Dementia incidence continues to increase with age in the oldest-old: The 90+ Study. Ann Neurol 2010; 67:114-121.
4. US Census Bureau. US interim projections by age, sex, race, and Hispanic origin [online]. Available at: Www.census.gov/ipc/www/usinterimproj/. Accessed September 21, 2009.
5. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: Ten years later. Arch Neurol 2009;66: 1447-1455.
6. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-308. (Pubitemid 29120227)
7. DeCarli C. Mild cognitive impairment: Prevalence, prognosis, aetiology, and treatment. Lancet Neurol 2003;2:15-21. (Pubitemid 37443340)
8. Panza F, D'Introno A, Colacicco AM, et al. Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry 2005;13:633-644. (Pubitemid 41197234)
9. Paganini-Hill A, Ross RK, Henderson BE. Prevalence of chronic disease and health practices in a retirement community. J Chronic Dis 1986;39:699-707. (Pubitemid 16046319)
10. US Census Bureau. Census 2000 summary file 2 (SF 2) 100-percent data: PCT3: Sex by age [online]. Available at: Factfinder.census.gov. Accessed February 7, 2011.
11. US Census Bureau. 2002 American community survey summary tables: PCT033: Sex by age by educational attainment for the population 18 years and over [online]. Available at: Factfinder.census.gov/. Accessed February 7, 2011.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
13. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test, 2nd ed. San Antonio, TX: Psychological Corporation; 2000.
14. Benton AL, Hamsher K, Sivan AB. Multilingual Aphasia Examination, 3rd ed. Iowa City, IA: AJA Associates; 1983.
15. Morris JC, Mohs R, Rogers H, Fillenbaum G, Heyman A. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988;24:641-652. (Pubitemid 19054370)
16. Wechsler D. WAIS-III Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation- Harcourt Brace & Company; 1997.
17. Whittle C, Corrada MM, Dick M, et al. Neuropsychological data in nondemented oldest-old: The 90+ Study. J Clin Exp Neuropsychol 2007;29:290-299. (Pubitemid 46598776)
18. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-329. (Pubitemid 12117513)
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th. ed. Washington, DC: American Psychiatric Association; 1994.
20. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994;6:45-58. (Pubitemid 24167129)
21. Corrada MM, Brookmeyer R, Berlau D, Paganini-Hill A, Kawas CH. Prevalence of dementia after age 90: Results from The 90+ Study. Neurology 2008;71:337-343.
22. Petersen RC. Mild cognitive impairment: Current research and clinical implications. Semin Neurol 2007;27:22-31. (Pubitemid 46239036)
23. Larrieu S, Letenneur L, Orgogozo JM, et al. Incidence and outcome of mild cognitive impairment in a populationbased prospective cohort. Neurology 2002;59:1594-1599. (Pubitemid 35387068)
24. Palmer K, Backman L, Winblad B, Fratiglioni L. Mild cognitive impairment in the general population: Occurrence and progression to Alzheimer disease. Am J Geriatr Psychiatry 2008;16:603-611.
25. Hong TB, Zarit SH, Johansson B. Mild cognitive impairment in the oldest old: A comparison of two approaches. Aging Ment Health 2003;7:271-276. (Pubitemid 36917125)
26. Johansson B, Zarit SH. Early cognitive markers of the incidence of dementia and mortality: A longitudinal population-based study of the oldest old. Int J Geriatr Psychiatry 1997;12:53-59. (Pubitemid 27067375)
27. Busse A, Hensel A, Guhne U, Angermeyer MC, Riedel- Heller SG. Mild cognitive impairment: Long-term course of four clinical subtypes. Neurology 2006;67:2176-2185. (Pubitemid 46035473)
28. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia: Meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009; 119:252-265.
29. Peltz CB, Corrada MM, Berlau DJ, Kawas CH. Cognitive impairment in non-demented oldest-old: Prevalence and relationship to cardiovascular risk factors. Alzheimer Dement (in press 2011).
30. Buerger K, Teipel SJ, Zinkowski R, et al. CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology 2002;59:627-629. (Pubitemid 34920005)
31. Petersen RC, Waring SC, Smith GE, Tangalos EG, Thibodeau SN. Predictive value of APOE genotyping in incipient Alzheimer's disease. Ann NY Acad Sci 1996;802:58-69. (Pubitemid 27055500)
32. Hsiung GY, Sadovnick AD, Feldman H. Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: Data from the Canadian Study of Health and Aging. CMAJ 2004;171:863-867. (Pubitemid 39371553)
33. DeCarli C, Mungas D, Harvey D, et al. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology 2004;63:220-227. (Pubitemid 38971118)
34. Juva K, Verkkoniemi A, Viramo P, et al. APOE ε4 does not predict mortality, cognitive decline, or dementia in the oldest old. Neurology 2000;54:412-415. (Pubitemid 30078074)